Viking Global (LAB) holds 58.65M shares (~15%) of Standard BioTools
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Standard BioTools Amendment No. 2 to a Schedule 13G/A: Viking Global Investors and affiliated entities report beneficial ownership of 58,651,170 shares of Common Stock. The filing states this represents 15.0% of 390,141,000 shares outstanding as of March 31, 2026. The amendment removes David C. Ott as a reporting person effective March 31, 2026.
The disclosure breaks the position into 39,296,310 shares held through Viking Global Opportunities (VGOP) and 19,354,860 shares held through Viking Global Opportunities Drawdown (VGOD), and shows shared voting and dispositive power across the listed Viking entities and two executive committee members.
Positive
- None.
Negative
- None.
Key Figures
Aggregate beneficial ownership: 58,651,170 shares
VGOP direct holdings: 39,296,310 shares
VGOD direct holdings: 19,354,860 shares
+2 more
5 metrics
Aggregate beneficial ownership
58,651,170 shares
aggregate held by VGI and affiliates
VGOP direct holdings
39,296,310 shares
directly owned by VGOP
VGOD direct holdings
19,354,860 shares
directly owned by VGOD
Percent of class
15.0%
based on 390,141,000 shares outstanding as of March 31, 2026
Shares outstanding anchor
390,141,000 shares
shares outstanding as of March 31, 2026 per issuer 10-Q
Key Terms
beneficially own, shared dispositive power, Rule 13d-3, Schedule 13G/A amendment
4 terms
beneficially own regulatory
"VGI beneficially owns 58,651,170 shares of Common Stock"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Rule 13d-3 regulatory
"Based on Rule 13d-3 under the Act, VGI may be deemed to beneficially own"
Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.
Schedule 13G/A amendment regulatory
"Amendment No. 2 to a Schedule 13G/A is being filed to remove Mr. Ott"
FAQ
What stake does Viking Global report in Standard BioTools (LAB)?
Viking Global and affiliates report beneficial ownership of 58,651,170 shares, equal to 15.0% of the company's 390,141,000 shares outstanding as of March 31, 2026. The holdings are split between VGOP and VGOD entities.
Why was an amendment filed on this Schedule 13G/A?
The amendment removes David C. Ott as a reporting person effective March 31, 2026, stating he retired and is no longer a beneficial owner of any reported shares; signatures are dated May 15, 2026.
What is the ownership percentage basis used in the filing?
Percentages are calculated using 390,141,000 shares outstanding as of March 31, 2026, reported in the issuer's Form 10-Q referenced in the filing; Viking's aggregate stake is listed as 15.0%.